Navigation Links
Epizyme, Inc. Provides Third Quarter 2013 Financial Results and Corporate Update
Date:10/22/2013

he Company's website beginning approximately two hours after the event.

About Epizyme, Inc.Epizyme, Inc. is a clinical stage biopharmaceutical company creating personalized therapeutics for patients with genetically defined cancers. Epizyme has built a proprietary product platform that the company uses to create small molecule inhibitors of a 96-member class of enzymes known as histone methyltransferases, or HMTs. HMTs are part of the system of gene regulation, referred to as epigenetics, that controls gene expression. Genetic alterations can result in changes to the activity of HMTs, making them oncogenic (cancer-causing). By focusing on the genetic drivers of cancers, Epizyme's targeted science seeks to match the right medicines with the right patients for a personalized approach to cancer treatment.

For more information, visit www.epizyme.com and connect with us on Twitter at @EpizymeRx.EPIZYME, INC. CONSOLIDATED BALANCE SHEET DATA (UNAUDITED)(Amounts in thousands)September 30,December 31,20132012Cash and cash equivalents

$
39,575$
97,981Total assets

147,350103,511Deferred revenue

50,70669,445Redeemable convertible preferred stock (Series A, B and C)

-76,156Stockholders' equity (deficit)

87,283(51,126)EPIZYME, INC.CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)(Amounts in thousands except per share data)Three Months Ended September 30,Nine Months Ended September 30,2013201220132012Collaboration revenue

$
8,444$
5,331$
32,165$
36,327Operating expenses:Research and development

14,5849,25841,88227,385General and administrative

3,5871,6309,6645,175Total operating expenses

18,17110,88851,54632,560(Loss) income from operations

(9,727)4,443(19,381)3,767Other income (expense), net

235(32)69Net (loss) income

$
(9,704)$
4,448$
(19,413)$'/>"/>

SOURCE Epizyme, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Epizyme, Inc. Reports Second Quarter 2013 Financial Results
2. New Resource Provides Herb Industry With Sources of Quality Specifications
3. Amsterdam Molecular Therapeutics Provides Business Update for the Third Quarter 2011
4. Generex Provides Update on Generex Oral-lyn™ Clinical & Regulatory Program
5. Health Diagnostic Laboratory, Inc. Provides Largest Corporate Gift in Science Museum of Virginias History
6. Generex Subsidiary Antigen Express Provides Update on AE37 Cancer Vaccines Clinical & Regulatory Strategy
7. Oxford Finance Provides $15 Million Senior Secured Credit Facility to Private Equity Backed Healthcare Services Company
8. Insmed Incorporated Provides Corporate Update
9. Van Andel Research Institute Study Provides New Details of Fundamental Cellular Process
10. Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012
11. Genomic Health Announces Year-End 2011 Financial Results, Provides 2012 Financial Outlook
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... (PRWEB) July 23, 2014 StemGenex® ... therapy in the US aimed at improving the lives ... newest clinical study for Parkinson’s disease. StemGenex believes ... stem cell therapy are paramount when providing care to ... study makes stem cell therapy accessible to the millions ...
(Date:7/23/2014)... Iowa (PRWEB) July 23, 2014 DuPont ... the business as vice president of Agricultural Biotechnology (ABT), ... Biotechnology where he served most recently as president, chief ... biotechnology and business leadership in the seed and crop ... said Paul E. Schickler , president of DuPont ...
(Date:7/23/2014)... , July 23, 2014 regulated information -- UCB ... and development pipeline with positive topline results from ... . This study was designed to evaluate the efficacy ... 200 mg/day, without titration) compared to placebo, as ... partial-onset seizures, not fully controlled despite treatment with ...
(Date:7/23/2014)... 23, 2014  GrowBLOX Sciences, Inc. (OTCQB: GBLX), a medical ... filing for two medical marijuana dispensary locations in ... to the Clark County, Nevada dispensary ... as previously announced.  GrowBLOX Sciences, CEO Craig ... new applications for dispensaries in the City of ...
Breaking Biology Technology:StemGenex® Gives Hope to Parkinson’s Patients through New Stem Cell Clinical Study 2StemGenex® Gives Hope to Parkinson’s Patients through New Stem Cell Clinical Study 3DuPont Pioneer Names Neal Gutterson to Lead Agricultural Biotechnology 2DuPont Pioneer Names Neal Gutterson to Lead Agricultural Biotechnology 3Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 3Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 4Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 5Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 6Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 7GrowBLOX Sciences, Inc. Files for Two Additional Medical Marijuana Dispensaries in Las Vegas 2GrowBLOX Sciences, Inc. Files for Two Additional Medical Marijuana Dispensaries in Las Vegas 3
... Va., June 20 Insmed Inc. (Nasdaq:,INSM), a ... it intends to request a hearing before The ... earlier Staff Determination,to delist the Company,s common stock ... a letter from The NASDAQ Stock Market ("NASDAQ") ...
... June 20, 2008 / b3c newswire / ... organization (CMO) for the development and production of ... 2,500 L multi-process production suite. Hence, Rentschler Biotechnologie ... of 30, 250, 500 and 2,500 liters, allowing ...
... InterMune, Inc.,(Nasdaq: ITMN ) today announced that ... InterMune, will present at the Jefferies 2nd,Annual Healthcare Conference ... p.m. EDT., To access a live audio webcast ... on to the investor relations page of InterMune,s,corporate website ...
Cached Biology Technology:Insmed to Request Hearing Before NASDAQ Panel to Review NASDAQ Staff Determination 2Rentschler Biotechnologie Extends Capacities for Mammalian Cell Culture Manufacturing 2
(Date:7/23/2014)... , , , , ... , , , , ... extend healthy lifespan. The idea, they argue, would be to target the... , , ... , , , , , ... , , , , , , , Medicine focuses almost ...
(Date:7/23/2014)... has the entire country in its grip is affecting more ... responsible for the proliferation of a heat-loving amoeba commonly found ... springs, which the drought has made warmer than usual this ... infection caused by this parasite after swimming in several area ... an individual and travels to the brain. Nose plugs can ...
(Date:7/23/2014)... The planet,s soil releases about 60 billion tons of ... more than that released by burning fossil fuels. This ... release of carbon is balanced by carbon coming into ... matter, as well as by the underground activities of ... that rising temperatures increase the rate of soil respiration. ...
Breaking Biology News(10 mins):Strategy proposed for preventing diseases of aging 2Strategy proposed for preventing diseases of aging 3Strategy proposed for preventing diseases of aging 4Strategy proposed for preventing diseases of aging 5Diseases of another kind 2Climate change and the soil 2
... are ineffective and their continuation endangers ecosystems that ... worlds population depend, United Nations University experts warn ... for sweeping change. In a blunt assessment, ... Headquarters, New York, UNUs Canadian-based International Network on ...
... Biologist John Smol has been named as one of ... Royal Canadian Geographical Society. His half-brother, biologist Jules Blais, ... one of Canada,s most prestigious in the environmental sciences. ... work to Canadian society. Smol is series ...
... Atmel(R) Corporation (Nasdaq:,ATML), an inventor and leading ... that its FingerChip(R) fingerprint sensor,solution has been selected ... PC.,Rise will showcase this biometrics-capable LCD PC during ... as a standard feature enhances consumer,friendliness in the ...
Cached Biology News:Coastal management cooperation, enforcement key to avoid pending crisis for millions: U.N. experts 2Coastal management cooperation, enforcement key to avoid pending crisis for millions: U.N. experts 3Coastal management cooperation, enforcement key to avoid pending crisis for millions: U.N. experts 4Coastal management cooperation, enforcement key to avoid pending crisis for millions: U.N. experts 5Coastal management cooperation, enforcement key to avoid pending crisis for millions: U.N. experts 6Atmel's FingerChip Biometric Sensor Selected by Rise Computer for its Robust Security 2Atmel's FingerChip Biometric Sensor Selected by Rise Computer for its Robust Security 3
Reported to support murine B lymphocytes, hematopoietic tissue from bone marrow, B cells stimulated with lipopolysaccharide, T lymphocytes, and a variety of hybrid cells....
... Eagle's medium have been developed ... most widely used modification is ... a modification of Minimum Essential ... a higher concentration of vitamins ...
... a fixative useful for routine procedures. Hollandes ... stable and will decalcify small bone specimens. ... be stained successfully with most stains, and ... red blood cell membranes and cosinophil and ...
... Gas Chromatograph/Mass Spectrometer, utilizing many of ... Plus, offers high throughput and excellent ... performance-to-cost ratio. Like the GCMS-QP2010 Plus, ... velocity for optimum separation, 20 temperature ...
Biology Products: